Tilly J L, Aihara T, Nishimori K, Jia X C, Billig H, Kowalski K I, Perlas E A, Hsueh A J
Department of Gynecology and Obstetrics, Stanford University School of Medicine, California 94305-5317.
Endocrinology. 1992 Aug;131(2):799-806. doi: 10.1210/endo.131.2.1322283.
The ligand specificity and biochemical properties of the human (h) FSH receptor are poorly characterized due to the low abundance of these receptors and the limited availability of human tissues. Using a fragment of rat FSH receptor cDNA, we screened a human testicular cDNA library and obtained a FSH receptor cDNA covering the entire amino acid-coding region. After transfection of a human fetal kidney cell line (293) with the hFSH receptor cDNA, radioligand receptor analysis revealed the presence of high affinity (Kd, 1.7 x 10(-9) M) FSH-binding sites on the plasma membrane. Both recombinant and wild-type hFSH displaced [125I]hFSH binding, with ED50 values of 25 and 70 ng/ml, respectively, whereas hLH, hCG, and hTSH were ineffective. Although human, rat(r), and ovine FSH as well as equine CG competed for rat testicular FSH receptor binding, only hFSH and rFSH interacted effectively with the recombinant hFSH receptor, suggesting that species-specific ligand recognition exists between human and rodent receptors. After incubation of transfected cells with hFSH, but not recombinant hLH or hCG, a dose-dependent increase (ED50, 10 ng/ml) in extracellular cAMP accumulation was observed, indicating a functional coupling of the expressed human receptor with the endogenous adenyl cyclase. In cells cotransfected with the FSH receptor expression plasmid and a luciferase reporter gene driven by the promoter of a cAMP-responsive gene, treatment with hFSH, but not hCG, resulted in a dose-dependent increase in luciferase activity. Northern blot analysis using a cRNA probe derived from the human receptor cDNA indicated the presence of multiple FSH receptor mRNA transcripts (7.0, 4.2, and 2.5 kilobases) in RNA prepared from human follicular phase ovary, but not from human corpus luteum or placenta. Additionally, two FSH-binding sites of 76 and 112 kilodaltons were detected in transfected 293 cells after ligand/receptor cross-linking and sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis. These results demonstrate the expression of functional hFSH receptor with unique ligand specificity and provide new data on the biochemical properties of the human receptor at the mRNA and protein levels.
由于人促卵泡激素(h)受体丰度低且人体组织来源有限,其配体特异性和生化特性尚未得到充分表征。我们利用大鼠促卵泡激素受体cDNA片段筛选人睾丸cDNA文库,获得了覆盖整个氨基酸编码区的促卵泡激素受体cDNA。将人促卵泡激素受体cDNA转染人胚肾细胞系(293)后,放射性配体受体分析显示质膜上存在高亲和力(解离常数Kd为1.7×10⁻⁹ M)的促卵泡激素结合位点。重组型和野生型hFSH均可取代[¹²⁵I]hFSH的结合,其半数有效剂量(ED50)分别为25和70 ng/ml,而hLH、hCG和hTSH则无效。尽管人、大鼠(r)和绵羊促卵泡激素以及马绒毛膜促性腺激素(eCG)均可竞争大鼠睾丸促卵泡激素受体的结合,但只有hFSH和rFSH能与重组人促卵泡激素受体有效相互作用,这表明人和啮齿动物受体之间存在物种特异性配体识别。用hFSH(而非重组hLH或hCG)孵育转染细胞后,观察到细胞外环磷酸腺苷(cAMP)积累呈剂量依赖性增加(ED50为10 ng/ml),表明所表达的人受体与内源性腺苷酸环化酶存在功能偶联。在同时转染促卵泡激素受体表达质粒和由cAMP反应基因启动子驱动的荧光素酶报告基因的细胞中,用hFSH(而非hCG)处理导致荧光素酶活性呈剂量依赖性增加。用人促卵泡激素受体cDNA制备的cRNA探针进行Northern印迹分析表明,在人卵泡期卵巢制备的RNA中存在多种促卵泡激素受体mRNA转录本(7.0、4.2和2.5千碱基),而在人黄体或胎盘中则未检测到。此外,在配体/受体交联及十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析后,在转染的293细胞中检测到76和112千道尔顿的两个促卵泡激素结合位点。这些结果证明了具有独特配体特异性的功能性hFSH受体的表达,并在mRNA和蛋白质水平上提供了关于人受体生化特性的新数据。